To mark its 10th anniversary, Claire’s Place Foundation has launched a website that seeks to connect the community of…
Articles by Margarida Maia, PhD
Olgram has raised €1.5 million (about $1.77 million) in seed funding from investors to speed its development of antibiotics…
Health regulators in Australia have approved Trikafta (elexacaftor/tezacaftor/ivacaftor) to treat people with cystic fibrosis (CF), ages 12 years…
Trikafta, a medication that combines three different therapies (elexacaftor/tezacaftor/ivacaftor), is safe and effective in children with cystic fibrosis…
Parents of children and young adults with cystic fibrosis (CF) in Ontario sent a video appeal to the head…
Two bacterial species known to be frequent sources of lung infection in people with cystic fibrosis (CF) —…